Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose esketamine with thoracic paravertebral block in thoracoscopic lung cancer surgery
ChiCTR2300069557Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in bronchial carcinoma and postoperative pain (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: pain score and quality of recovery. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
bronchial carcinomapostoperative pain
Beyond the preview
Go deeper on ChiCTR2300069557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069557.